Evidence map›Paper›PMID 24501131›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.

Falk Nimmerjahn, Anja Lux

Abstract readComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Dengue and severe dengue.Clinical microbiology reviews · 2025
    Review
  3. Review
  4. The Genomic Organization of theFrontiers in immunology · 2021
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review article: Research on dengue during World War II revisited.The American journal of tropical medicine and hygiene · 2014
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Falk NimmerjahnInstitute of Genetics, Department of Biology, University of Erlangen-Nuremberg, Erlangen 91058, Germany.
Anja Lux

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibody-Dependent EnhancementAntigens, CDDengueDengue VirusHumansLeukocyte Immunoglobulin-like Receptor B1Receptors, ImmunologicAntigens, CDLeukocyte Immunoglobulin-like Receptor B1LILRB1 protein, humanReceptors, Immunologic

Identifiers

PMID24501131
PMCPMC3932889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.